Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mick P L Renkens

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The New England Journal of Medicine|May 8, 2024
Microplastics and Nanoplastics in AtheromasDeborah N Kalkman, Mick P L Renkens, Maik J Grundeken
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 24, 2023
Anatomical predictors for suture-based closure of the patent foramen ovale: A multicenter experienceLars S Witte, Mick P L Renkens, Aleksandra Gąsecka, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|April 2, 2023
Angiography-Based Superficial Wall Strain of De Novo Stenotic Coronary Arteries: Serial Assessment of Vessels Treated with Bioresorbable Scaffold or Drug-Eluting StentXinlei Wu, Mick P L Renkens, Laura Kerkmeijer, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 25, 2021
Non-Culprit MACE Rate in LRP: The Influence of Optimal Medical Therapy Using DAPT and StatinsMick P L Renkens, Gary S Mintz, Rebecca Torguson, et al.
Journal of Cardiovascular Development and Disease|April 25, 2025
Prevalence of Patent Foramen Ovale in Patients with Non-Obstructive Coronary Artery Disease (PROVA) StudyAbdelhak El Bouziani, Lars S Witte, Rutger G T Feenstra, et al.
JACC. Cardiovascular Interventions|October 28, 2025
Core Laboratory Comparison of Angiography-Derived Indexes of Microvascular Resistance Versus Pressure-wire IMR and Absolute ResistanceTsung-Ying Tsai, Ali Aldujeli, Danielle C J Keulards, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 17, 2025
Impact of elevated lipoprotein(a) on epicardial coronary flow conductance and endoluminal atherosclerotic disease distributionMick P L Renkens, Tsung-Ying Tsai, Pruthvi C Revaiah, et al.
JACC. Advances|January 20, 2026
Lipoprotein(a) and the Early Diagnosis, Complexity, and Extent of Coronary Artery Disease and Myocardial InfarctionCasper F Coerkamp, Victor A Verpalen, Kaoutar Bouhbouh, et al.
Expert Review of Cardiovascular Therapy|September 11, 2024
Lipoprotein(a) in interventional cardiology: identifying patients at highest risk of recurrent cardiovascular events through early recognition - a case based reviewMick P L Renkens, Casper F Coerkamp, Lars S Witte, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 6, 2021
Long-term clinical outcomes of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting stents: final five-year results of the AIDA randomised clinical trialLaura S M Kerkmeijer, Mick P L Renkens, Ruben Y G Tijssen, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The New England Journal of Medicine|May 8, 2024
Microplastics and Nanoplastics in AtheromasDeborah N Kalkman, Mick P L Renkens, Maik J Grundeken
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 24, 2023
Anatomical predictors for suture-based closure of the patent foramen ovale: A multicenter experienceLars S Witte, Mick P L Renkens, Aleksandra Gąsecka, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|April 2, 2023
Angiography-Based Superficial Wall Strain of De Novo Stenotic Coronary Arteries: Serial Assessment of Vessels Treated with Bioresorbable Scaffold or Drug-Eluting StentXinlei Wu, Mick P L Renkens, Laura Kerkmeijer, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 25, 2021
Non-Culprit MACE Rate in LRP: The Influence of Optimal Medical Therapy Using DAPT and StatinsMick P L Renkens, Gary S Mintz, Rebecca Torguson, et al.
Journal of Cardiovascular Development and Disease|April 25, 2025
Prevalence of Patent Foramen Ovale in Patients with Non-Obstructive Coronary Artery Disease (PROVA) StudyAbdelhak El Bouziani, Lars S Witte, Rutger G T Feenstra, et al.
JACC. Cardiovascular Interventions|October 28, 2025
Core Laboratory Comparison of Angiography-Derived Indexes of Microvascular Resistance Versus Pressure-wire IMR and Absolute ResistanceTsung-Ying Tsai, Ali Aldujeli, Danielle C J Keulards, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 17, 2025
Impact of elevated lipoprotein(a) on epicardial coronary flow conductance and endoluminal atherosclerotic disease distributionMick P L Renkens, Tsung-Ying Tsai, Pruthvi C Revaiah, et al.
JACC. Advances|January 20, 2026
Lipoprotein(a) and the Early Diagnosis, Complexity, and Extent of Coronary Artery Disease and Myocardial InfarctionCasper F Coerkamp, Victor A Verpalen, Kaoutar Bouhbouh, et al.
Expert Review of Cardiovascular Therapy|September 11, 2024
Lipoprotein(a) in interventional cardiology: identifying patients at highest risk of recurrent cardiovascular events through early recognition - a case based reviewMick P L Renkens, Casper F Coerkamp, Lars S Witte, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 6, 2021
Long-term clinical outcomes of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting stents: final five-year results of the AIDA randomised clinical trialLaura S M Kerkmeijer, Mick P L Renkens, Ruben Y G Tijssen, et al.
Pageof 2